Healthcare & Life Sciences
Nuvig Therapeutics
United Statesnuvigtx.com/
Nuvig Therapeutics is a series a startup based in United States. 1 investor tracked.
Activeseries-b
series-b
Stage
2020
Founded
2
Investors
About Nuvig Therapeutics
Nuvig Therapeutics is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Nuvig Therapeutics is a biotechnology company developing immune-modulating therapies that target chronic inflammatory and autoimmune diseases, with a lead candidate NVG-2089 that mimics sialylated IgG interaction with Type II Fcγ receptors and has progressed through Phase 1 and Phase 2 clinical trials.
Explore Nuvig Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.